Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ALX-1393

🥰Excellent
Catalog No. T14198Cas No. 949164-09-4

ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord. Antiinjurious effects on thermal, mechanical and chemical stimuli in rat models of acute pain.

ALX-1393

ALX-1393

🥰Excellent
Purity: 99.73%
Catalog No. T14198Cas No. 949164-09-4
ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord. Antiinjurious effects on thermal, mechanical and chemical stimuli in rat models of acute pain.
Pack SizePriceAvailabilityQuantity
1 mg$1,380In Stock
5 mg$2,800In Stock
10 mg$3,780In Stock
25 mg$5,620In Stock
50 mg$7,590In Stock
100 mg$9,870In Stock
1 mL x 10 mM (in DMSO)$2,880In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "ALX-1393"

Select Batch
Purity:99.73%
ee:95.26%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord. Antiinjurious effects on thermal, mechanical and chemical stimuli in rat models of acute pain.
In vivo
ALX1393 (i.c.v.; 25, 50, and 100 μg) suppresses the late-phase response in the formalin test in normal rats without affecting motor performance and demonstrates dose-dependent inhibition of mechanical and cold hyperalgesia. [1]
Chemical Properties
Molecular Weight395.42
FormulaC23H22FNO4
Cas No.949164-09-4
SmilesC(OC[C@@H](C(O)=O)N)(C1=C(OCC2=CC=CC=C2)C=CC=C1)C3=CC(F)=CC=C3
Relative Density.1.263 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 11 mg/mL (27.82 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5290 mL12.6448 mL25.2896 mL126.4478 mL
5 mM0.5058 mL2.5290 mL5.0579 mL25.2896 mL
10 mM0.2529 mL1.2645 mL2.5290 mL12.6448 mL
20 mM0.1264 mL0.6322 mL1.2645 mL6.3224 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ALX-1393 | purchase ALX-1393 | ALX-1393 cost | order ALX-1393 | ALX-1393 chemical structure | ALX-1393 in vivo | ALX-1393 formula | ALX-1393 molecular weight